Physicians at the Milton and Carroll Petrie Department of Urology continue to innovate and expand treatment options for patients with prostate cancer. Our Precision Urology™ approach involves integration of multiple variables and imaging data for diagnosis and treatment decision making, so patients with prostate cancer can be assured of our commitment to comprehensive and personalized care.
Ash Tewari, MBBS, MCh, FRCS, Chairman of the Department of Urology, is a leader in robotic prostate surgery, considered among the best robotic prostate cancer surgeons in the world. He has performed more than 5,500 robotic prostatectomies, making him one of the most experienced robotic surgeons. In order to minimize the damage to the nerves responsible for erectile function, Dr. Tewari pioneered the performance of a completely athermal technique (no use of cautery or heat energy) during robotic prostatectomy. Also, he developed the total reconstruction technique, in which the support structures of the urinary mechanism are restored following prostate removal, for faster continence recovery.
Mount Sinai Health System is at the forefront of diagnostic imaging for prostate cancer, specifically ultrasound guided fusion biopsy. We are one of two test centers in the world collaborating with Philips Health Care and helping refine fusion biopsy technology and developing applications for guided focal therapies.